Cyclopharm Limited (ASX:CYC)

Australia · Delayed Price · Currency is AUD

0.7400

-0.0350 (-4.52%)

Apr 16, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medical Imaging Systems			26.34M	-	-	-	-
Technegas			-	24.51M	19.74M	17.53M	17.01M
Technegas Growth			-	24.16%	12.65%	3.03%	9.57%
Molecular Imaging			-	340.46K	392.48K	153.09K	-
Molecular Imaging Growth			-	-13.25%	156.38%	-	-
Total			26.34M	24.85M	20.14M	17.68M	17.01M
Total Growth			5.97%	23.43%	13.89%	3.93%	9.57%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Asia Pacific			8.67M	9.54M	5.92M	5.39M	5.25M
Asia Pacific Growth			-9.10%	61.08%	9.78%	2.77%	9.67%
Europe			14.81M	12.17M	11.65M	10.14M	8.74M
Europe Growth			21.76%	4.42%	14.96%	15.93%	4.72%
Canada			2.74M	2.96M	2.46M	2.05M	2.56M
Canada Growth			-7.50%	20.50%	19.73%	-19.80%	19.25%
Other			117.37K	299.98K	107.60K	100.45K	463.79K
Other Growth			-60.87%	178.79%	7.11%	-78.34%	87.41%
Total			26.34M	24.96M	20.14M	17.68M	17.01M
Total Growth			5.51%	23.97%	13.89%	3.93%	9.57%

Source: S&P Global Market Intelligence.